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Abstract
Background: The use of thickeners is a standard therapy for decreasing episodes of regurgitation or
vomiting in infants. However, it remains to be investigated whether thickener is effective for vomiting and/
or chronic respiratory symptoms in children with cerebral palsy.
Methods:  We enrolled 18 neurologically impaired children caused by cerebral palsy, with
gastroesophageal reflux disease. In the first part of this study (pH monitoring), subjects were randomly
allocated to two groups: fed with a high-pectin diet [enteral formula: pectin liquid = 2:1 (v/v)], or a low-
pectin diet [enteral formula: pectin liquid = 3:1 (v/v)]. Two-channel esophageal pH monitoring was
performed over 48 h. In the second part (clinical trial), subjects were fed a high- or low-pectin diet and
non-pectin diet for 4 weeks in a crossover manner. Nurses recorded the feeding volume, number of
episodes of vomiting, volume of gastric residue, episodes of cough and wheeze, frequency of using oxygen
for dyspnea, and the day when the child could return to school. Cough and wheeze were recorded as a
cough-score.
Results: The median value for the % time pH < 4 at the lower and upper esophagus was significantly
decreased with a high-pectin diet [9.2% (6.2–22.6) vs. 5.0% (3.1–13.1); P < 0.01, 3.8% (2.9–11.2) vs. 1.6%
(0.9–8.9); P < 0.01 (interquartile range), non-pectin and high-pectin, respectively]. The number of reflux
episodes per day and duration of longest reflux were decreased significantly with a high-pectin, but not
with a low-pectin diet. The median number of episodes of vomiting decreased significantly with a high-
pectin diet [2.5/week (1.0–5.0) vs. 1.0 (1.0–1.5), P < 0.05]. The median cough-score was significantly
decreased by both concentrations of pectin [8.5/week (1.0–11.5) vs. 2.0/week (0.0–3.0), fed with a high-
pectin diet; 7.0/week (1.0–14.5) vs. 1.0/w (0.0–5.0), fed with a low-pectin diet, P < 0.05].
Conclusion: Pectin liquid partially decreased gastroesophageal reflux as measured by eshophageal pH
monitoring, and might improve vomiting and respiratory symptoms in children with cerebral palsy.
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Background
Gastroesophageal reflux (GER) appears to be a common,
persistent, and severe disorder in children with neurologic
impairment [1-3]. The estimated incidence of GER in
patients with cerebral palsy ranges from 32 to 75% [4,5].
Reflux episodes not only cause gastrointestinal symp-
toms, such as episodes of regurgitation or vomiting, hae-
matemesis, and reflux esophagitis, but also respiratory
problems, such as recurrent respiratory infections, persist-
ent cough, life-threatening apneic episodes, and respira-
tory failure during fairly minor respiratory infections.
Respiratory problems play a major role in the quality of
life and life expectancy of these children [1-6].
Several medical options are available for the management
of gastroesophageal reflux disease (GERD), including
feeding changes, such as the elimination of cow's milk
protein from the diet, or the use of food thickeners in
infants, and pharmacological therapy for acid suppres-
sion: histamine-2 receptor antagonists/proton pump
inhibitors and prokinetics, and/or positioning therapy [7-
9]. Antireflux surgery is often considered for children with
GERD who have complications or persistent symptoms
and are unable to be weaned from medical therapies.
There have been reports that in neurologically impaired
children, conventional drug therapy with acid suppressors
or prokinetics is less effective and antireflux surgery is rec-
ommended to treat GERD symptoms [10-12]. However,
surgical treatment is associated with high operative risk
and is often not preferred. In addition, surgical treatment
is not sufficient in some patients with recurrent pneumo-
nia because although it effectively provides nutrition, and
improves feeding-related stresses, it may exacerbate GER
[13,14]. Use of thickeners is common and effective in
decreasing frequent episodes of regurgitation or vomiting
in infants [7-9,15,16], and in improving dysphagia in
handicapped patients [17,18]. However, it remains to be
investigated whether thickener is effective for GERD in
neurologically impaired children.
In this study, we investigated the effects of thickening of
food with two different concentrations of pectin liquid on
acid exposure and symptoms that might be attributed to
GER in children with cerebral palsy.
Methods
Subjects
We enrolled 18 patients (16 male and two female) with
cerebral palsy from two hospitals, Gunma University Hos-
pital and Gunma Rehabilitation Centre for the Physically
Handicapped Children, Gunma, Japan. The average age of
subjects was 11.7 ± 4.4 years old. All patients received
enteral formula through a naso-gastric tube. Tracheos-
tomy was used to treat two patients with dyspnea and
wheeze, and one with laryngeal edema.
Chief complaints of patients were as follows: 12 had
recurrent vomiting, six had chronic cough, and one had
chronic cough and laryngitis. Recurrent pneumonias were
present in four children. These symptoms were clinically
suspected to be caused by GER, based on the clinical
course and positive results in esophageal pH monitoring.
Esophageal pH monitoring results were considered
abnormal when the percentage of time that the pH is
below 4.0 at the lower esophagus, i.e. reflux index, was
greater than 4.0%. Clinical suspicion was formed follow-
ing exclusion of other causes of these symptoms, such as
organic or functional gastrointestinal disorders (for
patients with vomiting) or respiratory or immunological
problems (for patients with respiratory symptoms). Only
two patients were of average weight. The rest were all
below the third percentile. None of the patients had
undergone antireflux surgery. Ten of 18 patients were
given histamine-2 receptor antagonists, (Gaster; Astellas
Pharma, Tokyo, Japan) as prior drug treatment for GER.
We excluded patients who underwent surgical operation
for GERD.
Test enteral formula and thickener
We used an enteral formula (K4A; Q.P., Tokyo, Japan)
with pectin liquid (REF-P1; Q.P.) added as a thickener.
The composition of the enteral formula per 100 mL was
100 kcal, 4.5 g protein, 16 g carbohydrate, and 2.7 g lipid.
The composition of the pectin liquid per 100 mL was 9
kcal, 0.2 g protein, 0.6 g carbohydrate, 0.1 g lipid, and 76
mg sodium.
Gastric contents and gas were aspirated through a
nasogastric tube. After nurses injected pectin liquid
through the nasogastric tube, the enteral formula was con-
tinuously injected into the stomach over 30 min.
Measurement of formula viscosity
Enteral formula and pectin liquid were mixed and kept at
23 ± 1°C in a water bath for 5 min after being stirred 100
times. The viscosity was measured at 23 ± 1°C, at 20 rpm,
with a No. 2 rotor using a Brookfield viscometer (Tokyo
Keiki, Tokyo, Japan).
Esophageal pH monitoring measurement
In the first part of this study, we performed esophageal pH
monitoring over 48 hours for each subject. A single crystal
antimony multi-use pH catheter (Synectics Medical, Bar-
carena, Portugal) with two channels [the end of the cath-
eter, and 7 cm (5 cm for two patients under 6 years of age)
above the end] was placed and connected to a portable
digital data recorder (Digitrapper pH 400; Medtronic,
Skovlunde, Denmark). Prior to passage, the pH catheterBMC Gastroenterology 2008, 8:11 http://www.biomedcentral.com/1471-230X/8/11
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was calibrated at room temperature in pH 7.01 and pH
1.07 buffer solutions, according to per the manufacturer's
protocol. The catheter pH electrode was passed transna-
sally and positioned 3 cm above the proximal margin of
both diaphragms. The correct position of the catheter was
confirmed by X-rays.
Subjects were randomly allocated to two groups. Patients
in group A (n = 9) were fed the enteral formula including
a high concentration of pectin liquid [enteral formula:
pectin liquid = 2:1 (v/v)] or the enteral formula mixed
with water added to a similar volume as the pectin liquid.
Four subjects in group A were fed with a high-pectin diet
on the first day, and with a non-pectin diet on the second
day. The other five subjects in group A were fed in the
reverse order. Patients in group B (n = 9) were fed with a
low-pectin diet [enteral formula: pectin liquid = 3:1 (v/v)]
or non-pectin diet. Treatment with acid suppressors or
prokinetics, (Gasmotin; Dainippon Sumitomo Pharma,
Osaka, Japan) was stopped 3 days before esophageal pH
monitoring.
After recording, the single crystal antimony multi-use pH
catheter was removed and data from the Digitrapper pH
400 were uploaded to a designated computer using Poly-
gramNet software (Medtronic). The median values for the
% time pH < 4 at the lower and upper esophagus, number
of reflux episodes per day and duration of longest reflux
episode, and number of reflux episodes longer than 5 min
were analyzed. Reflux index was defined as the % time pH
< 4 at the lower esophagus.
Clinical trial
In the second part of the study, to elucidate the clinical
effects of pectin liquid on GERD symptoms, four patients
in group A were fed with a high-pectin diet for 4 weeks,
followed by a non-pectin diet for 4 weeks. Five other
patients were fed in the reverse order. Nine patients in
group B were fed with a low-pectin or non-pectin diet.
During the final week of each 4-week trial period, nurses
recorded the feeding volume, number of episodes of vom-
iting, volume of gastric residue, episodes of cough and
wheeze, frequency of using oxygen for dyspnea, and the
day when the child could return to school, on the special
sheet that we provided. At the end of each day, the
number of each event was counted and recorded on the
special patient chart. High fever and episodes of bradycar-
dia were also recorded.
To investigate in a single-blinded manner, a nurse differ-
ent from the one who injected the enteral formula was on
duty to record the data. Every 8 h, if the patient had cough
or wheeze more than once, it was counted as 1 point. The
cough-score was the sum of points during 1 week of
recording. The maximum number of points was 21. Treat-
ment with acid suppressors or prokinetics was continued
during the test period.
Ethical considerations
Informed consent was obtained from the mother of each
subject. This study was approved by the Human Investiga-
tion Committee of Gunma University on 17 February
2005.
Statistical analysis
Age and viscosity of enteral formula are reported as the
means ± SD. Other variables were reported as the median
value and interquartile range. Statistical significance was
tested by the χ2 test, unpaired Student's t test, or Wil-
coxon's signed rank test, as appropriate. P < 0.05 was
regarded as significant. All analyses were carried out using
StatMate software (ATOMS, Tokyo, Japan).
Results
Formula viscosity
The viscosity of enteral formula and pectin liquid was 17
± 1 mPa￿s and 44 ± 2 mPa￿s (n = 5), respectively. The vis-
cosity of the high-pectin diet (enteral formula: pectin liq-
uid = 200 mL: 100 mL) was 3000 ± 50 mPa￿s, and that of
a low-pectin content diet (enteral formula: pectin liquid =
300 mL: 100 mL) was 1200 ± 40 mPa￿s (n = 5).
Esophageal pH monitoring
The median values for the % time pH < 4 at the lower and
upper esophagus with the high-pectin diet was signifi-
cantly decreased [9.2% (6.2–22.6) vs. 5.0% (3.1–13.1); P
< 0.01, 3.8% (2.9–11.2) vs. 1.6% (0.9–8.9); P < 0.01
(interquartile range), non-pectin and a high-pectin,
respectively] (Fig. 1A, B). Reflux index decreased by 16.4
to 81.5%. It was normalized in four of nine patients after
fed with a high-pectin diet. There was no significant differ-
ence between the median values for the % time pH < 4 at
the lower and upper esophagus with the low-pectin diet
[7.6% (5.0–15.2) vs. 7.6% (6.7–19.7), 2.2% (2.0–6.4 vs.
3.3% (1.9–7.0), non-pectin and a low-pectin, respec-
tively) (Fig. 2A, B). Other parameters of esophageal pH
monitoring are shown in Table 1. The number of reflux
episodes per day and duration of longest reflux episode
were decreased significantly with the high-pectin, but not
with the low-pectin diet. There was no significant differ-
ence between the number of reflux episodes longer than 5
min with and without pectin liquid.
Clinical effects
The clinical effects of pectin liquid are summarized in
Table 2. The median number of episodes of vomiting
decreased significantly with the high-pectin diet. There
was no significant difference in the amount of gastric res-
idue with bleeding and gastric residue > 25 mL betweenBMC Gastroenterology 2008, 8:11 http://www.biomedcentral.com/1471-230X/8/11
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the two groups. However, the total gastric residue was sig-
nificantly decreased by the low-pectin diet. The median
cough-score was significantly decreased by both concen-
trations of pectin liquid. Four patients had less wheezing
and the frequency of using oxygen for dyspnea was
decreased in three patients when fed with pectin. There
were no significant differences in the total volume of feed-
ing and the day when the child could return to school
between the groups. There were no patients with high
fevers or bradycardia due to reflux episodes during the test
period.
Discussion
Thickening of food is commonly used for the treatment of
GER in infants. Thickeners significantly decrease recurrent
episodes of regurgitation or vomiting and thickening is an
easy modification [7-9]. However, there have been no pre-
vious reports on the use of thickeners to decrease symp-
toms of GERD in children with cerebral palsy.
In our study, we first confirmed that viscosity of the
enteral formula with pectin liquid increased in a dose-
dependent manner. The viscosity of enteral formula was
increased approximately 70-fold by the low-pectin and
180-fold by the high-pectin diet. We noted that the liquid
meal changed to a semi-solid meal following addition of
pectin liquid.
We found that only the high-pectin diet improved the %
time pH < 4 at both the lower and upper esophagus.
Table 1: Results of esophageal pH monitoring
Group A
(high-pectin)
Group B
(low-pectin)
Pectin (-) Pectin (+) Pectin (-) Pectin (+)
Number of reflux episodes (/day) 151
(94–205)
100*
(72–113)
112
(62–139)
146
(72–153)
Number of long reflux episodes (> 5 min) (/day) 4
(3–9)
3
(2–6)
1
(0–2)
3
(1–3)
Duration of longest reflux episode (min) 13
(8–46)
10*
(5–26)
5
(2–23)
8
(5–21)
Values reported as the median and interquartile range.
*, P < 0.05, Wilcoxon's signed rank test
Percent time pH < 4 at the lower esophagus (A) and % time  pH < 4 at the upper esophagus (B) in patients fed with a high- pectin content diet Pectin (+), a high-pectin content diet Figure 1
Percent time pH < 4 at the lower esophagus (A) and 
% time pH < 4 at the upper esophagus (B) in patients 
fed with a high-pectin content diet. Pectin (+), a high-
pectin content diet. Pectin (-), non-pectin diet. Each vertical 
bar represents the median value. **, P < 0.01, Wilcoxon's 
signed rank test.
Percent time pH < 4 at the lower esophagus (A) and pH < 4  time at the upper esophagus (B) in patients fed with a low- pectin content diet Pectin (+), a low-pectin content diet Figure 2
Percent time pH < 4 at the lower esophagus (A) and 
% time pH < 4 time at the upper esophagus (B) in 
patients fed with a low-pectin content diet. Pectin (+), 
a low-pectin content diet. Pectin (-), non-pectin diet. Each 
vertical bar represented the median value. n.s., not signifi-
cant, Wilcoxon's signed rank test.BMC Gastroenterology 2008, 8:11 http://www.biomedcentral.com/1471-230X/8/11
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Reflux index decreased by 16.4 to 81.5%. It was normal-
ized in four of nine patients. These data suggest that a
semi-solid meal with added pectin decreased GER,
although the effect often was partial.
We also found that both concentrations of pectin liquid
had clinical effects on decreasing respiratory symptoms
such as cough or wheeze, and tended to decrease the fre-
quency of oxygen use for dyspnea, although the trends
were not significant.
It is not clear why a low-pectin content diet improved
chronic respiratory symptoms in patients with GERD,
without improving the % time pH < 4 or reflux episodes
during pH monitoring. There have been previous studies
with similar results that thickened infant formula
decreases regurgitation episodes, without improving
reflux [15,19]. One possible reason is that only acid reflux
can be detected by pH monitoring. Wenzl et al. [16] have
reported the effect of thickened formula on decreasing the
number of infant regurgitation episodes, based on intralu-
minal impedance, which suggests the importance of non-
acid reflux. Another possible hypothesis is that the physi-
ological effects of pectin on gastrointestinal motility, such
as improving bowel movements [20,21], may be related
to a decrease in GER-related symptoms. Further investiga-
tion is needed to determine the mechanism responsible
for the relief of GERD symptoms by pectin.
Our major concern was that increasing viscosity of food
by pectin liquid might cause delayed gastric emptying as
previously reported [22-24]. Di Lorenzo et al. [22] have
reported that pectin delayed gastric emptying and
increased satiety in obese subjects, and Sandhu et al. [23]
have concluded that pectin supplementation delayed gas-
tric emptying of both liquid and solid meals in normal
human subjects. We investigated the volume of gastric res-
idue by the aspiration of residual gastric contents.
There are several techniques to measure gastric emptying,
such as breath hydrogen test and scintigraphy. However,
we simply evaluated gastric residue in this study to deter-
mine gastric retention after every feeding time, rather than
to check gastric emptying once or twice using some phys-
iological techniques. Our results indicated that the low
concentrations of pectin liquid used in the present study
did not cause delayed gastric emptying, and pectin even
decreased gastric residue, which might have been because
pectin liquid improved bowel motility, as previously
reported [20,21].
Finally, we found that only a high-pectin diet decreased
the number of episodes of vomiting. These data indicate
that we may consider the use of a high concentration of
pectin liquid when the effect of regular concentration of
this thickener is not sufficient to decrease reflux episodes,
especially for vomiting. We can evaluate the effect of pec-
tin by means of not only improvement in clinical symp-
toms but also two-channel pH monitoring. We were
concerned about the possibility that pectin might cause
gastric retention, which was refuted even with a high con-
centration. However, we should also note other possible
adverse effects of pectin on fat absorption and intestinal
solubility or absorption of ferrous iron [25,26].
Conclusion
Pectin liquid might improve vomiting, respiratory symp-
toms, and GER in children with cerebral palsy, and may
be considered as an alternative therapy for GERD that can
be added to pharmacological therapy.
Table 2: Clinical effects of pectin
Group A
(high-pectin)
Group B
(low-pectin)
Pectin (-) Pectin (+) Pectin (-) Pectin (+)
Total feeding (mL/week) 6930
(5775–6970)
6950
(5775–7000)
7000
(5950–7700)
7000
(5600–7700)
Number of vomiting (/week) 2.5
(1.0–5.0)
1.0*
(1.0–1.5)
0.0
(0.0–0.5)
0.0
(0.0–1.0)
Gastric bleeding (/week) 1.0
(0.0–1.5)
0.0
(0.0–0.0)
0.0
(0.0–0.0)
0.0
(0.0–0.0)
Gastric residue (> 25 mL) (/week) 3.0
(1.5–4.5)
4.0
(1.0–4.0)
2.0
(0.0–4.0)
0.0
(0.0–0.5)
Total gastric residue (/week) 4.5
(1.5–6.0)
4.0
(1.0–4.0)
2.0
(0.0–4.5)
0.0*
(0.0–0.5)
Cough&wheeze (points/week) 8.5
(1.0–11.5)
2.0*
(0.0–3.0)
7.0
(1.0–14.5)
1.0*
(0.0–5.0)
Desaturation (/week) 3.0
(0.0–4.5)
1.0
(0.0–3.0)
0.0
(0.0–5.5)
0.0
(0.0–2.5)
Values reported as the median and interquartile range.
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